Emmanuella Bema Twumasi1, Pearl Ihuoma Akazue2, Kwaku Kyeremeh1, Theresa Manful Gwira2, Jennifer Keiser3, Fidelis Cho-Ngwa4, Adrian Flint5, Barbara Anibea1, Emmanuel Yeboah Bonsu1, Richard K Amewu1, Linda Eva Amoah6, Regina Appiah-Opong6, Dorcas Osei-Safo1. 1. Department of Chemistry, University of Ghana, Accra, Ghana. 2. West African Centre for Cell Biology and Infectious Diseases, Department of Biochemistry, Cell and Molecular Biology, University of Ghana, Accra, Ghana. 3. Helminth Drug Development Unit, Department of Medical Parasitology and Infection Biology, Swiss Tropical and Public Health Institute, Basel, Switzerland. 4. Biotechnology Unit laboratories, Faculty of Science, University of Buea, Buea, Cameroon. 5. School of Sociology, Politics and International Studies, University of Bristol, Bristol, United Kingdom. 6. Noguchi Memorial Institute for Medical Research, University of Ghana, Accra, Ghana.
Abstract
BACKGROUND: Ghana is endemic for some neglected tropical diseases (NTDs) including schistosomiasis, onchocerciasis and lymphatic filariasis. The major intervention for these diseases is mass drug administration of a few repeatedly recycled drugs which is a cause for major concern due to reduced efficacy of the drugs and the emergence of drug resistance. Evidently, new treatments are needed urgently. Medicinal plants, on the other hand, have a reputable history as important sources of potent therapeutic agents in the treatment of various diseases among African populations, Ghana inclusively, and provide very useful starting points for the discovery of much-needed new or alternative drugs. METHODOLOGY/PRINCIPAL FINDINGS: In this study, extracts of fifteen traditional medicines used for treating various NTDs in local communities were screened in vitro for efficacy against schistosomiasis, onchocerciasis and African trypanosomiasis. Two extracts, NTD-B4-DCM and NTD-B7-DCM, prepared from traditional medicines used to treat schistosomiasis, displayed the highest activity (IC50 = 30.5 μg/mL and 30.8 μg/mL, respectively) against Schistosoma mansoni adult worms. NTD-B2-DCM, also obtained from an antischistosomal remedy, was the most active against female and male adult Onchocera ochengi worms (IC50 = 76.2 μg/mL and 76.7 μg/mL, respectively). Antitrypanosomal assay of the extracts against Trypanosoma brucei brucei gave the most promising results (IC50 = 5.63 μg/mL to 18.71 μg/mL). Incidentally, NTD-B4-DCM and NTD-B2-DCM, also exhibited the greatest antitrypanosomal activities (IC50 = 5.63 μg/mL and 7.12 μg/mL, respectively). Following the favourable outcome of the antitrypanosomal screening, this assay was selected for bioactivity-guided fractionation. NTD-B4-DCM, the most active extract, was fractionated and subsequent isolation of bioactive constituents led to an eupatoriochromene-rich oil (42.6%) which was 1.3-fold (IC50 <0.0977 μg/mL) more active than the standard antitrypanosomal drug, diminazene aceturate (IC50 = 0.13 μg/mL). CONCLUSION/SIGNIFICANCE: These findings justify the use of traditional medicines and demonstrate their prospects towards NTDs drug discovery.
BACKGROUND: Ghana is endemic for some neglected tropical diseases (NTDs) including schistosomiasis, onchocerciasis and lymphatic filariasis. The major intervention for these diseases is mass drug administration of a few repeatedly recycled drugs which is a cause for major concern due to reduced efficacy of the drugs and the emergence of drug resistance. Evidently, new treatments are needed urgently. Medicinal plants, on the other hand, have a reputable history as important sources of potent therapeutic agents in the treatment of various diseases among African populations, Ghana inclusively, and provide very useful starting points for the discovery of much-needed new or alternative drugs. METHODOLOGY/PRINCIPAL FINDINGS: In this study, extracts of fifteen traditional medicines used for treating various NTDs in local communities were screened in vitro for efficacy against schistosomiasis, onchocerciasis and African trypanosomiasis. Two extracts, NTD-B4-DCM and NTD-B7-DCM, prepared from traditional medicines used to treat schistosomiasis, displayed the highest activity (IC50 = 30.5 μg/mL and 30.8 μg/mL, respectively) against Schistosoma mansoni adult worms. NTD-B2-DCM, also obtained from an antischistosomal remedy, was the most active against female and male adult Onchocera ochengi worms (IC50 = 76.2 μg/mL and 76.7 μg/mL, respectively). Antitrypanosomal assay of the extracts against Trypanosoma brucei brucei gave the most promising results (IC50 = 5.63 μg/mL to 18.71 μg/mL). Incidentally, NTD-B4-DCM and NTD-B2-DCM, also exhibited the greatest antitrypanosomal activities (IC50 = 5.63 μg/mL and 7.12 μg/mL, respectively). Following the favourable outcome of the antitrypanosomal screening, this assay was selected for bioactivity-guided fractionation. NTD-B4-DCM, the most active extract, was fractionated and subsequent isolation of bioactive constituents led to an eupatoriochromene-rich oil (42.6%) which was 1.3-fold (IC50 <0.0977 μg/mL) more active than the standard antitrypanosomal drug, diminazene aceturate (IC50 = 0.13 μg/mL). CONCLUSION/SIGNIFICANCE: These findings justify the use of traditional medicines and demonstrate their prospects towards NTDs drug discovery.
Authors: Michelle C Stanton; Abigail Best; Matthew Cliffe; Louise Kelly-Hope; Nana-Kwadwo Biritwum; Linda Batsa; Alex Debrah Journal: Trop Med Int Health Date: 2015-12-18 Impact factor: 2.622
Authors: Benjamin G Koudou; Dziedzom K de Souza; Nana-Kwadwo Biritwum; Roland Bougma; Meite Aboulaye; Elizabeth Elhassan; Simon Bush; David H Molyneux Journal: Lancet Infect Dis Date: 2018-02-03 Impact factor: 25.071
Authors: Dziedzom Komi de Souza; Jewelna Osei-Poku; Julia Blum; Helena Baidoo; Charles Addoquaye Brown; Bernard Walter Lawson; Michael David Wilson; Moses John Bockarie; Daniel Adjei Boakye Journal: Pan Afr Med J Date: 2014-02-26
Authors: Richard Kwamla Amewu; Patrick Amoateng; Patrick Kobina Arthur; Prince Asare; Isaac Asiamah; Daniel Boamah; Isaac Darko Otchere; Cedric Dzidzor Amengor; Edmund Ekuadzi; Kelly Chibale; Susan Jane Farrell; Regina Appiah-Oppong; Dorcas Osei-Safo; Kevin David Read; Ian Hugh Gilbert; Dorothy Yeboah-Manu Journal: PLoS Negl Trop Dis Date: 2022-09-15